Keywords: Cytinedix, Aldagen, Regenerative medicine, Ischemic stroke

Cytomedix expands in regenerative medicines, buying Aldagen

Article | 10 February 2012

Print This

USA-based regenerative wound care specialist Cytomedix (OTC.BB: CMXI.OB) said yesterday that it has completed the acquisition of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in